Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (71-80 of 242) with videos related to

Pageof 25
Sort By:
BJU International|September 25, 2020
Genetic variability in 13q33 and 9q34 is linked to aggressiveness patterns and a higher risk of progression of non-muscle-invasive bladder cancer at the time of diagnosisLouis Lenfant, Geraldine Cancel-Tassin, Stéphane Gazut, et al.
Analytical and Quantitative Cytopathology and Histopathology|January 11, 2013
Prostate cancer with clear cell features and an unusual nested-like pattern of growth: a case reportJustine Varinot, Sarah Drouin, Morgan Rouprêt, et al.
BJU International|January 21, 2015
Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patientsVéronique Phé, Morgan Rouprêt, Olivier Cussenot, et al.
Genes|December 1, 2020
The Genetic Complexity of Prostate CancerEva Compérat, Gabriel Wasinger, André Oszwald, et al.
European Urology|March 7, 2006
Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type AEva Compérat, André Reitz, Annick Delcourt, et al.
Urologic Oncology|March 2, 2010
Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tractSylvia Scarpini, Morgan Rouprêt, Raphaële Renard-Penna, et al.
Virchows Archiv : an International Journal of Pathology|September 2, 2024
A single-center retrospective comparison of pT1 substaging methods in bladder cancerJohannes Kläger, Maximilian C Koeller, André Oszwald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinomaAdriana von Teichman, Eva Compérat, Silvia Behnke, et al.
Virchows Archiv : an International Journal of Pathology|March 11, 2017
Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patientsAdeline Furudoï, Justine Varinot, Véronique Phe, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Leiomyosarcoma of the renal pelvis]Michaël Peyromaure, Kaili Mao, Eva Compérat, et al.
Pageof 25

Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
BJU International|September 25, 2020
Genetic variability in 13q33 and 9q34 is linked to aggressiveness patterns and a higher risk of progression of non-muscle-invasive bladder cancer at the time of diagnosisLouis Lenfant, Geraldine Cancel-Tassin, Stéphane Gazut, et al.
Analytical and Quantitative Cytopathology and Histopathology|January 11, 2013
Prostate cancer with clear cell features and an unusual nested-like pattern of growth: a case reportJustine Varinot, Sarah Drouin, Morgan Rouprêt, et al.
BJU International|January 21, 2015
Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patientsVéronique Phé, Morgan Rouprêt, Olivier Cussenot, et al.
Genes|December 1, 2020
The Genetic Complexity of Prostate CancerEva Compérat, Gabriel Wasinger, André Oszwald, et al.
European Urology|March 7, 2006
Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type AEva Compérat, André Reitz, Annick Delcourt, et al.
Urologic Oncology|March 2, 2010
Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tractSylvia Scarpini, Morgan Rouprêt, Raphaële Renard-Penna, et al.
Virchows Archiv : an International Journal of Pathology|September 2, 2024
A single-center retrospective comparison of pT1 substaging methods in bladder cancerJohannes Kläger, Maximilian C Koeller, André Oszwald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinomaAdriana von Teichman, Eva Compérat, Silvia Behnke, et al.
Virchows Archiv : an International Journal of Pathology|March 11, 2017
Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patientsAdeline Furudoï, Justine Varinot, Véronique Phe, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Leiomyosarcoma of the renal pelvis]Michaël Peyromaure, Kaili Mao, Eva Compérat, et al.
Pageof 25